LPS-induced Migration of Peritoneal B-1 Cells is Associated with Upregulation of CXCR4 and Increased Migratory Sensitivity to CXCL12
Overview
Affiliations
B-1 cells, which constitute a predominant lymphocyte subset in serosal cavities and produce most of natural antibodies, are subdivided into the CD5(+) B-1a and CD5(-) B-1b cell subpopulations, but the differential roles of B-1a and B-1b cells are not well understood. We report that B-1a cells preferentially migrate out of the peritoneal cavity and upregulate the expression of CXCR4 with heightened sensitivity to CXCL12 and CXCL13 upon LPS treatment compared to B-1b and B-2 cells. Whereas B-1a cells were slightly more abundant than B-1b and B-2 cells in the homeostatic condition, the number of B-1a cells preferentially decreased 48 hr after LPS treatment. The decrease in the peritoneal B-1a cell number was accompanied with increased migration of B-1a cells toward CXCL-12 and CXCL-13 in in vitro transmigration assay using peritoneal B cells from LPS treated mice. The expression level of CXCR4, but not of CXCR5, was also more prominently increased in B-1a cells upon LPS stimulation. LPS-stimulated B-1a cells did not accumulate in omental milky spots in contrast to B-2 cells. These results suggest that B-1a cells actively migrate out of the peritoneal cavity through the regulation of the migratory responsiveness to chemokines and actively participate in systemic immune responses.
Riese J, Kleinwort A, Hannemann M, Hahnel C, Kersting S, Schulze T Eur J Immunol. 2024; 54(12):e2350882.
PMID: 39344245 PMC: 11628879. DOI: 10.1002/eji.202350882.
B lymphocytes in COVID-19: a tale of harmony and discordance.
Mansourabadi A, Aghamajidi A, Dorfaki M, Keshavarz F, Shafeghat Z, Moazzeni A Arch Virol. 2023; 168(5):148.
PMID: 37119286 PMC: 10147999. DOI: 10.1007/s00705-023-05773-y.
Bird M, Hebbes C, Tamang A, Willets J, Thompson J, Guerrini R Br J Pharmacol. 2023; 180(17):2298-2314.
PMID: 37021779 PMC: 10953342. DOI: 10.1111/bph.16088.
Busse M, Zenclussen A Cells. 2022; 11(17).
PMID: 36078100 PMC: 9454497. DOI: 10.3390/cells11172690.
Therapeutic Potential of B-1a Cells in Intestinal Ischemia-Reperfusion Injury.
Royster W, Ochani M, Aziz M, Wang P J Surg Res. 2021; 268:326-336.
PMID: 34399355 PMC: 8678159. DOI: 10.1016/j.jss.2021.06.070.